MEMBER PREVIEW
The oral treatment targets persistent HSV sores in certain immunocompromised patients who have not responded to available antivirals.
FREE MEMBER LOGIN
LOGIN TO CONTINUE READING.
Create or use your free IMG login to read standard articles. Important and Premium analysis also requires an active ₹99 or ₹199 plan.
The public preview and the member article share the same canonical page. No personalised investment recommendation is provided.